Overview
Yuri Taniguchi practices in Yokohama, Japan. Taniguchi is rated as an Experienced expert by MediFind in the treatment of Autoimmune Hemolytic Anemia. Their top areas of expertise are Glycogen Storage Disease Type 6, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and EGFR Positive Lung Cancer.
Their clinical research consists of co-authoring 21 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Autoimmune Hemolytic Anemia.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Glycogen Storage Disease Type 6Taniguchi isAdvanced. Learn about Glycogen Storage Disease Type 6.
- Experienced
- Autoimmune Hemolytic AnemiaTaniguchi isExperienced. Learn about Autoimmune Hemolytic Anemia.
- EGFR Positive Lung CancerTaniguchi isExperienced. Learn about EGFR Positive Lung Cancer.
- Legionnaire DiseaseTaniguchi isExperienced. Learn about Legionnaire Disease.
- Lung CancerTaniguchi isExperienced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Taniguchi isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).
- PneumoniaTaniguchi isExperienced. Learn about Pneumonia.